GERON CORP (GERN) Stock Profile — Insider Trades & Financials

Revenue$0

Net Income-$28.9M

EPS$-0.13

Market Cap$1.1B

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

John Scarlett

CEO & Executive Director

Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.

Employees: 82
Headquarters: FOSTER CITY, CA, United States
Website: www.geron.com

Peer ComparisonRevenue ($B)

▾

⚡

Core Efficiency

ROE?

-12.78%

ROA?

-5.06%

D/E Ratio?

1.53

📊

Profitability Ratios

Current Ratio?

4.66

Loading comparison...

Earnings Calendar

Filing history and next expected filing date

Next Expected Filing

Jul 19, 2026 (in 103 days)

Annual Report (10-K) — Based on filing pattern

Jul 19, 2026

Predicted10-K

Mar 2, 2026

10-KQ4 202510d after period end

Nov 7, 2025

10-QQ3 20253d after period end

Aug 6, 2025

10-QQ2 20255d after period end

May 7, 2025

10-QQ1 20255d after period end

Feb 27, 2025

10-KQ4 20246d after period end

Nov 7, 2024

10-QQ3 20243d after period end

Aug 8, 2024

10-QQ2 20243d after period end

May 2, 2024

10-QQ1 20246d after period end

Loading company sections...

GERON CORP

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Earnings Calendar

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness